Arbutus Biopharma Corp Capital Expenditures Incurred but Not yet Paid
Arbutus Biopharma Corp (ABUS) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2018-11-07
- Arbutus Biopharma Corp capital expenditures incurred but not yet paid for the quarter ending 2018-09-30 was $0.00.
- Arbutus Biopharma Corp capital expenditures incurred but not yet paid for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Arbutus Biopharma Corp capital expenditures incurred but not yet paid for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Arbutus Biopharma Corp capital expenditures incurred but not yet paid for the quarter ending 2017-12-31 was -$6.00K, a 100.76% decline year-over-year.
- Arbutus Biopharma Corp capital expenditures incurred but not yet paid for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Arbutus Biopharma Corp capital expenditures incurred but not yet paid for fiscal 2016 was $1.06M.
- Arbutus Biopharma Corp capital expenditures incurred but not yet paid for fiscal 2015 was $0.00.
- Arbutus Biopharma Corp capital expenditures incurred but not yet paid for fiscal 2014 was $0.00.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 9 month as first filed | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | -$6.00K derived: sum of 4 quarters · filed 2018-11-07 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | -$6.00K derived: sum of 3 quarters · filed 2018-08-03 | -$6.00K derived: sum of 4 quarters · filed 2018-11-07 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-04 | -$6.00K derived: sum of 2 quarters · filed 2018-05-04 | -$6.00K derived: sum of 3 quarters · filed 2018-11-07 | $66.00K derived: sum of 4 quarters · filed 2018-11-07 | |
| 2017-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$6.00K derived: sum of 2 quarters · filed 2018-11-07 | $66.00K derived: sum of 3 quarters · filed 2018-11-07 | $0.00 10-K · filed 2018-03-16 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | $72.00K derived: sum of 2 quarters · filed 2018-11-07 | $6.00K 10-Q · filed 2018-11-07 | -$6.00K 10-Q · filed 2017-11-02 | $2.29M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $72.00K 10-Q · filed 2018-08-03 | $72.00K 10-Q · filed 2018-08-03 | $2.29M derived: sum of 3 quarters · filed 2018-08-03 | $2.56M derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-03-31 | $1.43M 10-Q · filed 2018-05-04 | $2.22M derived: sum of 2 quarters · filed 2018-05-04 | $2.48M derived: sum of 3 quarters · filed 2018-05-04 | $2.48M derived: sum of 4 quarters · filed 2018-05-04 | |
| 2016-12-31 | $791.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $1.06M derived: sum of 2 quarters · filed 2018-03-16 | $1.06M derived: sum of 3 quarters · filed 2018-03-16 | $1.06M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $266.00K 10-Q · filed 2017-11-02 | $266.00K derived: sum of 2 quarters · filed 2017-11-02 | $266.00K 10-Q · filed 2017-11-02 | $266.00K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $0.00 derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 10-K · filed 2018-03-16 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |